Log in to save to my catalogue

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and ge...

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and ge...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b8b7499dd4d9446c941b6c08b5f8bee4

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

About this item

Full title

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2018-01, Vol.10 (1), p.48-62

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases with overlap in clinical presentation, neuropathology, and genetic underpinnings. The molecular basis for the overlap of these disorders is not well established. We performed a comparative unbiased mass spectrometry‐based proteomic analysis of front...

Alternative Titles

Full title

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b8b7499dd4d9446c941b6c08b5f8bee4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b8b7499dd4d9446c941b6c08b5f8bee4

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.201708202

How to access this item